HANGZHOU, China, Oct. 24 /PRNewswire-FirstCall/ -- Aida Pharmaceuticals, Inc. (OTC Bulletin Board: AIDA - News), one of mainland China’s leading pharmaceutical companies, today announced the Company will hold a press conference on Wednesday, November 1, 2006 at 3:00 PM CCT (2:00 AM EST) at Aida Pharmaceutical’s headquarters in Hangzhou, China. The press conference will follow a seminar for invited scientists and doctors to discuss Phase I trial results of the Company’s prospective cancer treatment, Rh-Apo2L, and Aida Pharmaceuticals’ intention to commence Phase II and III trials. Mr. Jin Biao, Chairman of Aida Pharmaceuticals, along with Chinese government officials, will address the press.
